These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37414753)
1. Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target. Qin B; Li Z; Tang K; Wang T; Xie Y; Aumonier S; Wang M; Yuan S; Cui S Nat Commun; 2023 Jul; 14(1):3999. PubMed ID: 37414753 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction. Lavigne M; Helynck O; Rigolet P; Boudria-Souilah R; Nowakowski M; Baron B; Brülé S; Hoos S; Raynal B; Guittat L; Beauvineau C; Petres S; Granzhan A; Guillon J; Pratviel G; Teulade-Fichou MP; England P; Mergny JL; Munier-Lehmann H Nucleic Acids Res; 2021 Jul; 49(13):7695-7712. PubMed ID: 34232992 [TBL] [Abstract][Full Text] [Related]
4. Anti-SARS-CoV-2 Activity of a Polyphenolic Complex from Maackia amurensis. Krylova NV; Iunikhina OV; Fedoreev SA; Pott AB; Persiyanova EV; Mishchenko NP; Tarbeeva DV; Shchelkanov MY Bull Exp Biol Med; 2023 Dec; 176(2):187-190. PubMed ID: 38191881 [TBL] [Abstract][Full Text] [Related]
5. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models. Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962 [TBL] [Abstract][Full Text] [Related]
6. Gallium maltolate has Bernstein LR; Zhang L Antivir Chem Chemother; 2020; 28():2040206620983780. PubMed ID: 33353394 [TBL] [Abstract][Full Text] [Related]
7. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D Cells; 2021 Dec; 11(1):. PubMed ID: 35011614 [TBL] [Abstract][Full Text] [Related]
8. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455 [TBL] [Abstract][Full Text] [Related]
9. Potential antiviral effects of pantethine against SARS-CoV-2. Abou-Hamdan M; Saleh R; Mani S; Dournaud P; Metifiot M; Blondot ML; Andreola ML; Abdel-Sater F; De Reggi M; Gressens P; Laforge M Sci Rep; 2023 Feb; 13(1):2237. PubMed ID: 36754974 [TBL] [Abstract][Full Text] [Related]
10. Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells. Dinesh Kumar N; Ter Ellen BM; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; van Gosliga D; Apperloo L; Carpaij OA; van den Berge M; Nawijn MC; Stienstra Y; Rodenhuis-Zybert IA; Smit JM Antimicrob Agents Chemother; 2022 Jan; 66(1):e0154321. PubMed ID: 34633839 [TBL] [Abstract][Full Text] [Related]
11. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro. Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661 [TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. Ciccosanti F; Di Rienzo M; Romagnoli A; Colavita F; Refolo G; Castilletti C; Agrati C; Brai A; Manetti F; Botta L; Capobianchi MR; Ippolito G; Piacentini M; Fimia GM Antiviral Res; 2021 Jun; 190():105064. PubMed ID: 33781803 [TBL] [Abstract][Full Text] [Related]
13. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Yuan S; Wang R; Chan JF; Zhang AJ; Cheng T; Chik KK; Ye ZW; Wang S; Lee AC; Jin L; Li H; Jin DY; Yuen KY; Sun H Nat Microbiol; 2020 Nov; 5(11):1439-1448. PubMed ID: 33028965 [TBL] [Abstract][Full Text] [Related]
14. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle. Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797 [TBL] [Abstract][Full Text] [Related]
15. New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19. de Almeida Marques DP; Andrade LAF; Reis EVS; Clarindo FA; Moraes TFS; Lourenço KL; De Barros WA; Costa NEM; Andrade LM; Lopes-Ribeiro Á; Coêlho Maciel MS; Corrêa-Dias LC; de Almeida IN; Arantes TS; Litwinski VCV; de Oliveira LC; Serafim MSM; Maltarollo VG; Guatimosim SC; Silva MM; Tsuji M; Ferreira RS; Barreto LV; Barbosa-Stancioli EF; da Fonseca FG; De Fátima Â; Coelho-Dos-Reis JGA Virus Res; 2024 Feb; 340():199291. PubMed ID: 38065303 [TBL] [Abstract][Full Text] [Related]
16. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Touret F; Gilles M; Barral K; Nougairède A; van Helden J; Decroly E; de Lamballerie X; Coutard B Sci Rep; 2020 Aug; 10(1):13093. PubMed ID: 32753646 [TBL] [Abstract][Full Text] [Related]